SIMIAN IMMUNODEFICIENCY VIRUS-RNA IS EFFICIENTLY ENCAPSIDATED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES

被引:125
|
作者
RIZVI, TA [1 ]
PANGANIBAN, AT [1 ]
机构
[1] UNIV WISCONSIN,MCARDLE LAB CANC RES,1400 UNIV AVE,MADISON,WI 53706
关键词
D O I
10.1128/JVI.67.5.2681-2688.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Packaging of retroviral RNA is attained through the specific recognition of a cis-acting encapsidation site (located near the 5' end of the viral RNA) by components of the Gag precursor protein. Human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) are two lentiviruses that lack apparent sequence similarity in their putative encapsidation regions. We used SIV vectors to determine whether HIV-1 particles can recognize the SIV encapsidation site and functionally propagate SIV nucleic acid. SIV nucleic acid was replicated by HIV-1 proteins. Thus, efficient lentivirus pseudotyping can take place at the RNA level. Direct examination of the RNA contents of virus particles indicated that encapsidation of this heterologous RNA is efficient. Characterization of deletion mutants in the untranslated leader region of SIV RNA indicates that only a very short region at the 5' end of the SIV RNA is needed for packaging. Comparison of this region with the corresponding region of HIV-1 reveals that both are marked by secondary structures that are likely to be similar. Thus, it is likely that a similar higher-order RNA structure is required for encapsidation.
引用
收藏
页码:2681 / 2688
页数:8
相关论文
共 50 条
  • [11] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    [J]. EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [12] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [13] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [14] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [15] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480
  • [16] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    [J]. JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148
  • [17] HEADACHE AND THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HOLLOWAY, RG
    KIEBURTZ, KD
    [J]. HEADACHE, 1995, 35 (05): : 245 - 255
  • [18] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REFERENCE MATERIALS
    OBRIEN, TA
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (03) : 272 - 276
  • [19] STRUCTURE AND FUNCTION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PAVLAKIS, GN
    [J]. SEMINARS IN LIVER DISEASE, 1992, 12 (02) : 103 - 107
  • [20] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA
    LUCHT, E
    ALBERT, J
    LINDE, A
    XU, WM
    BRYTTING, M
    LUNDEBERG, J
    UHLEN, M
    BRATT, G
    SANDSTROM, E
    HEIMDAHL, A
    NORD, CE
    WAHREN, B
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 156 - 162